Advertisement

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing

Dolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, Margaret Kasner, John L. Wagner, Beth Colombe, Patricia Cornett Farley, William O'Hara, Phyllis Flomenberg, Maria Werner-Wasik, Janet Brunner, Bijoyesh Mookerjee, Terry Hyslop, Mark Weiss and Neal Flomenberg

Article Information

Citation 
vol. 118 no. 17 4732-4739
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted July 5, 2011
  • Accepted August 17, 2011
  • Published online October 27, 2011.

Article Versions


Contributors 
  • Dolores Grosso, 1Kimmel Cancer Center,
  • Matthew Carabasi, 1Kimmel Cancer Center,
  • Joanne Filicko-O'Hara, 1Kimmel Cancer Center,
  • Margaret Kasner, 1Kimmel Cancer Center,
  • John L. Wagner, 1Kimmel Cancer Center,
  • Beth Colombe, 2Department of Tissue Typing,
  • Patricia Cornett Farley, 3Stem Cell Processing Laboratory,
  • William O'Hara, 4Department of Pharmacy,
  • Phyllis Flomenberg, 5Department of Infectious Diseases, and
  • Maria Werner-Wasik, 6Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA; and
  • Janet Brunner, 7Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI
  • Bijoyesh Mookerjee, 1Kimmel Cancer Center,
  • Terry Hyslop, 1Kimmel Cancer Center,
  • Mark Weiss, 1Kimmel Cancer Center,
  • Neal Flomenberg, 1Kimmel Cancer Center,

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output